Research Roundup: The Latest Science, Discoveries, And Breakthroughs
Each week, KFF Health News compiles a selection of health policy studies and briefs.
The independent source for health policy research, polling, and news.
221 - 240 of 112,346 Results
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Opinion writers discuss these public health matters.
A study by the CDC shows that women are less likely than men to wake up feeling rested, and they have a harder time falling and staying asleep. Thirty percent of adults surveyed sleep fewer than seven hours a night. Also: carbon pollution's effect on the food we eat; ultraprocessed food's link to increased dementia risk; and more.
Unlike other insurance giants, Humana had held off on shrinking benefits up until this point, Modern Healthcare reports. But in a change of events, President and CEO Jim Rechtin announced the company will be streamlining offerings in order to shrink the gap between expenses and federal payments, Modern Healthcare reported.
The unanimous ruling is a victory for First Choice Women’s Resource Centers. The case revolves around First Amendment concerns the center has regarding a subpoena to turn over donor lists and whether the center used misleading practices.
Skinny labeling, Stat explains, is when a generic drugmaker seeks approval to market a drug for a specific use other than those for which the brand-name medicine is prescribed as a way to avoid patent infringement lawsuits. The outcome of the hearing could affect access to generics.
Wednesday's Supreme Court ruling gives Republicans an opportunity to break up Black and Hispanic majority districts for partisan gain, The Washington Post reported. One activist in Louisiana, Press Robinson, who grew up in South Carolina during segregation, predicted that Republicans in Southern states would move aggressively to reshape the political landscape, The New York Times reported. “They are determined to see to it that we don’t have a voice at all,” he said.
On Wednesday, the Department of Justice rolled out dozens of planned changes to federal gun regulations, including rolling back a Biden-era measure that sought to end the "gun show loophole."
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health topics.
The jury attributed 88% of the fault to the University of Kansas Hospital Authority and 12% of the fault to LivaNova USA Inc., the medtech company that manufactured the device that was used in Stephen Nolte's heart surgery at KU Med. This is one of more than two dozen lawsuits filed against the University of Kansas Hospital Authority and LivaNova, the Kansas City Star reports.
According to the Centers for Disease Control and Prevention, roughly a dozen of the 34 people who became ill are younger than 5. Also in the news: consequences of covid screening; a report on deaths related to hepatitis B and C; the dangers of chatbots and bioterrorism; and more.
FDA staff have expressed concerns about the use of camizestrant to treat metastatic breast cancer and capivasertib for patients with metastatic hormone-sensitive prostate cancer. The Oncologic Drugs Advisory Committee will vote on these two drug applications Thursday.
Despite pushback from some members, the reconstituted Interagency Autism Coordinating Committee also recommended the establishment of safety measures to protect people who wander from their caregivers and to encourage Medicaid to set guidelines for diagnosis and possible health risks, Stat reported.
But NBC News reports that hospital CEOs pushed back during the House hearing Tuesday, saying high costs were a product of factors including low reimbursement rates and their obligation to treat sicker and sometimes uninsured patients. Meanwhile, a Gallup poll finds a record 55% of Americans report that their financial situation is worsening.
The last step necessary to clear the way to a settlement was delivered via a criminal sentence Tuesday by U.S. District Judge Madeline Cox Arleo, resolving thousands of lawsuits, AP reports. As part of the deal, Purdue will cease to exist and will be replaced by a new company, Knoa Pharma, with the aim of combating the opioid crisis.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
At least three pharma firms — Novartis, Amgen, and Eli Lilly — say they're closer to unraveling the mystery of lipoprotein(a), which is a more dangerous cousin to LDL cholesterol. Diet and exercise don't influence lp(a) levels, CNBC reported, and there is currently no medication for it.
© 2026 KFF